Christina Ackermann, Director at Verona Pharma plc (VRNA), sold 1,808 shares at $13.14 ($24K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market sale of $24k VRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BHC | SELL | 2021-06-04 | $7.7M | — | Filing → |
| BHC | BUY | 2020-03-11 | $160K | — | Filing → |
| BHC | SELL | 2019-08-13 | $153K | — | Filing → |